Adherence to infliximab therapy in inflammatory bowel disease patients in a real ‐life setting

CONCLUSIONSThe overall non‐adherence rate for infliximab use was 54.3%. Professional constraints and intentional non‐adherence were the leading causes of non‐adherence. Perineal disease and active CD were negatively related to adherence.

Source: Journal of Digestive Diseases - July 1, 2017 Category: Gastroenterology Authors: Laura Martelli, Anthony Lopez, Sophie Strobel, Silvio Danese, Xavier Roblin, C édric Baumann, Laurent Peyrin‐Biroulet Tags: Original article Source Type: research